CTS CORP
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements ‑ (Unaudited)
(in thousands except for share and per share data)
March 31, 2025
NOTE 1 — Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS”, “we”, “our”, “us” or the “Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, notes thereto, and other information included in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2024.
The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring items) necessary for a fair statement, in all material respects, of the financial position and results of operations for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. The results of operations for the interim periods are not necessarily indicative of the results for the entire year.
There have been no material changes in the Company’s significant accounting policies as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Immaterial Correction of Prior Period Error
The Company identified immaterial prior period errors in the consolidated financial statements related to the acquisition of SyQwest, LLC (“SyQwest”) as well as the foreign currency impact on certain long-term debt payments. The errors related to the SyQwest acquisition were due to errors with the calculation of revenue and cost of goods sold both prior to and subsequent to the acquisition date of July 29, 2024. The Company assessed the materiality of this change on prior period consolidated financial statements in accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (ASC Topic 250, Accounting Changes and Error Corrections). Based on this assessment, the Company concluded that these error corrections were material in the current period, but are not material to any previously presented consolidated financial statements. Accordingly, the Company corrected the previously reported immaterial errors for the year ended December 31, 2024 and the three and nine months ended September 30, 2024 in this Quarterly Report on Form 10-Q.
The financial reporting periods affected by this error include the Company’s previously reported audited consolidated financial statements for the fiscal year ended December 31, 2024 and the Company’s previously reported interim unaudited consolidated financial statements for the three and nine months ended September 30, 2024. In addition, the Company expects to present the corrected interim 2024 amounts in its 2025 consolidated interim financial statements upon the filing of each of its Quarterly Reports on Form 10-Q on a year-to-date basis as a correction to applicable 2024 periods. A summary of the immaterial corrections to the Company’s previously reported audited and unaudited consolidated financial statements follows.
Corrected Consolidated Statement of Earnings for the Year Ended December 31, 2024 (in thousands):
| Year Ended · Year Ended | ||||
|---|---|---|---|---|
| December 31, 2024 · December 31, 2024 | ||||
| Previously Reported · Corrections · As Corrected | ||||
| Net sales | $515,771 | $(1,015) | $514,756 | |
| Cost of goods sold | 326,621 | 580 | 327,201 | |
| Gross margin | 189,150 | (1,595) | 187,555 | |
| Operating earnings | 72,780 | (1,595) | 71,185 | |
| Other income (expense): | ||||
| Other income (expense), net | (1,603) | (1,047) | (2,650) | |
| Total other expense, net | (1,557) | (1,047) | (2,604) | |
| Earnings before income taxes | 71,223 | (2,642) | 68,581 | |
| Net earnings | $58,114 | $(2,642) | $55,472 | |
| Earnings per share: | ||||
| Basic | $1.91 | $1.82 | ||
| Diluted | $1.89 | $1.81 | ||
| Basic weighted – average common shares outstanding: | 30,408 | 30,408 | ||
| Effect of dilutive securities | 309 | 309 | ||
| Diluted weighted – average common shares outstanding: | 30,717 | 30,717 | ||
Corrected Consolidated Balance Sheet as of December 31, 2024 (in thousands):
| December 31, 2024 · December 31, 2024 | |||
|---|---|---|---|
| Previously Reported | Corrections | As Corrected | |
| ASSETS | |||
| Current Assets | |||
| Inventories, net | $53,578 | $(1,266) | $52,312 |
| Other current assets | 18,716 | (837) | 17,879 |
| Total current assets | 244,277 | (2,103) | 242,174 |
| Other Assets | |||
| Goodwill | 199,886 | 1,418 | 201,304 |
| Total other assets | 404,539 | 1,418 | 405,957 |
| Total Assets | $766,112 | $(685) | $765,427 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current Liabilities | |||
| Accrued expenses and other liabilities | 34,451 | 910 | 35,361 |
| Total current liabilities | 97,553 | 910 | 98,463 |
| Long-term debt | 91,253 | 1,047 | 92,300 |
| Total Liabilities | 235,262 | 1,957 | 237,219 |
| Shareholders’ Equity | |||
| Retained earnings | 655,493 | (2,642) | 652,851 |
| Total shareholders’ equity before treasury stock | 1,017,868 | (2,642) | 1,015,226 |
| Total shareholders’ equity | 530,850 | (2,642) | 528,208 |
| Total Liabilities and Shareholders’ Equity | $766,112 | $(685) | $765,427 |
Corrected Consolidated Statement of Cash Flows for the Year Ended December 31, 2024 (in thousands):
| Year Ended · Year Ended | |||
|---|---|---|---|
| December 31, 2024 · December 31, 2024 | |||
| Previously Reported | Corrections | As Corrected | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net earnings | $58,114 | $(2,642) | $55,472 |
| Changes in assets and liabilities, net of acquisitions: | |||
| Inventories | 11,893 | 580 | 12,473 |
| Other assets | 900 | 837 | 1,737 |
| Accrued expenses and other liabilities | (5,255) | 178 | (5,077) |
| Net cash provided by operating activities | 99,289 | (1,047) | 98,242 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Payments of long-term debt | (891,847) | 1,047 | (890,800) |
| Net cash (used in) provided by financing activities | $(27,935) | $1,047 | $(26,888) |
Corrected Consolidated Statement of Earnings for the Three and Nine Months Ended September 30, 2024 (in thousands):
| Three Months Ended · Three Months Ended · Nine Months Ended · Nine Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| September 30, 2024 · September 30, 2024 · September 30, 2024 · September 30, 2024 | |||||||||
| Previously Reported · Corrections · As Corrected · Previously Reported · Corrections · As Corrected | |||||||||
| Net sales | $132,424 | $(40) | $132,385 | $388,336 | $(40) | $388,296 | |||
| Cost of goods sold | 82,636 | 559 | 83,195 | 247,086 | 559 | 247,645 | |||
| Gross margin | 49,788 | (599) | 49,189 | 141,250 | (599) | 140,651 | |||
| Operating earnings | 21,475 | (599) | 20,876 | 53,775 | (599) | 53,176 | |||
| Earnings before income taxes | 22,447 | (599) | 21,848 | 53,872 | (599) | 53,273 | |||
| Net earnings | $18,683 | $(599) | $18,084 | $44,508 | $(599) | $43,909 | |||
| Earnings per share: | |||||||||
| Basic | $0.62 | $0.60 | $1.46 | $1.44 | |||||
| Diluted | $0.61 | $0.59 | $1.45 | $1.43 | |||||
| Basic weighted – average common shares outstanding: | 30,300 | 30,300 | 30,517 | 30,517 | |||||
| Effect of dilutive securities | 236 | 236 | 230 | 230 | |||||
| Diluted weighted – average common shares outstanding: | 30,536 | 30,536 | 30,747 | 30,747 | |||||
Corrected Consolidated Balance Sheet as of September 30, 2024 (in thousands):
| September 30, 2024 · September 30, 2024 | |||
|---|---|---|---|
| Previously Reported | Corrections | As Corrected | |
| ASSETS | |||
| Current Assets | |||
| Inventories, net | $57,288 | $(1,246) | $56,042 |
| Total current assets | 255,561 | (1,246) | 254,315 |
| Other Assets | |||
| Goodwill | 194,821 | 1,418 | 196,239 |
| Total other assets | 416,677 | 1,418 | 418,095 |
| Total Assets | $789,392 | $172 | $789,564 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current Liabilities | |||
| Accrued expenses and other liabilities | 37,249 | 771 | 38,020 |
| Total current liabilities | 103,799 | 771 | 104,570 |
| Total Liabilities | 258,586 | 771 | 259,357 |
| Shareholders’ Equity | |||
| Retained earnings | 643,088 | (599) | 642,489 |
| Total shareholders’ equity before treasury stock | 1,009,937 | (599) | 1,009,338 |
| Total shareholders’ equity | 530,806 | (599) | 530,207 |
| Total Liabilities and Shareholders’ Equity | $789,392 | $172 | $789,564 |
Corrected Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2024 (in thousands):
| Nine Months Ended · Nine Months Ended | ||||
|---|---|---|---|---|
| September 30, 2024 · September 30, 2024 | ||||
| Previously Reported · Corrections · As Corrected | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net earnings | $44,508 | $(599) | $43,909 | |
| Changes in assets and liabilities, net of acquisitions: | ||||
| Inventories | 11,346 | 559 | 11,905 | |
| Accrued expenses and other liabilities | (2,645) | 40 | (2,605) | |
| Net cash provided by operating activities | $73,335 | $ | - | $73,335 |
Corrected Fair Value of SyQwest Assets Acquired and Liabilities Assumed:
| Accounts receivable | $770 |
|---|---|
| Inventory | 7,939 |
| Other current assets | 1,475 |
| Property, plant and equipment | 985 |
| Other assets | 684 |
| Goodwill | 46,600 |
| Intangible assets | 76,100 |
| Fair value of assets acquired | 134,553 |
| Less fair value of liabilities acquired | (6,536) |
| Purchase price | $128,017 |
Accounting Pronouncements Recently Adopted
ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure”
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments' significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as existing segment disclosures and reconciliation required under ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for the interim periods beginning after December 15, 2024, with early adoption permitted. We adopted the guidance in our Annual Report on Form 10-K for the year ended December 31, 2024. See Note 17, “Segment Information,” for further information.
Recently issued accounting pronouncements not yet adopted
ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the reconciliation of the effective tax rate, as well as disclosure of income taxes paid, disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09. We will adopt the guidance when it becomes effective on a prospective basis.
ASU No. 2024-03, “Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses”
In November 2024, the FASB issued ASU 2024-03, Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional information about certain expenses in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03. We will adopt the guidance when it becomes effective on a prospective basis.
NOTE 2 – Revenue Recognition
CTS designs and manufactures sensors, actuators, and electronic components for original equipment manufacturers and the U.S. Government. For each contract with a customer, we determine the transaction price based on the consideration expected to be received by the Company in exchange for performing its obligations under the applicable contract. We allocate the transaction price to each distinct performance obligation to deliver a good or service, or a collection of goods and/or services, based on the relative standalone selling prices. We usually expect payment from our customers within 30 to 90 days from the shipping date or invoicing date, depending on our terms with the customer. None of our contracts as of March 31, 2025 contained a significant financing component. Differences between the amount of revenue recognized and the amount invoiced, collected from, or paid to our customers are recognized as contract assets or liabilities. Contract assets will be reviewed for impairment when events or circumstances indicate that they may not be recoverable.
To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing the most likely value method based on an analysis of historical experience and current facts and circumstances, which may require significant judgment. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.
The majority of our revenue is derived from contracts for sales of commercial products, which generally contain a single performance obligation. We generally recognize revenue at a point in time on the delivery date based on the shipping terms stipulated in the contract.
We also design, manufacture, and test products for certain customers under contracts that allow the customers to unilaterally terminate the contract for convenience, take control of any work in process, and pay us for costs incurred plus a reasonable profit. Revenue from these contracts is generally recognized over time as the work progresses, either as products are produced or services are rendered, because we generally do not have an alternative use for the completed assets produced and we have an enforceable right to payment for performance completed to date. These contracts may contain a single or multiple performance obligations. The accounting for these contracts involves applying significant judgment with respect to estimating total revenues, costs and profit for each performance obligation. We generally estimate revenue for these contracts using the costs incurred by the Company as we have determined it is most representative of the Company's cumulative efforts relative to the total expected efforts to satisfy the performance obligations.
See Note 9, “Commitments and Contingencies” for information about our product warranties.
Contract Assets and Liabilities
Contract assets and liabilities included in our Condensed Consolidated Balance Sheets are as follows:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Contract Assets | ||
| Unbilled customer receivables included in Other current assets | $3,687 | $4,104 |
| Total Contract Assets | $3,687 | $4,104 |
| Contract Liabilities | ||
| Customer advance payments included in Accrued expenses and other liabilities | $(850) | $(910) |
| Total Contract Liabilities | $(850) | $(910) |
During the three months ended March 31, 2025 the Company recognized $60 of revenue that was included in the contract liability balance at December 31, 2024.
Disaggregated Revenue
The following table presents revenues disaggregated by the major markets we serve:
| Three months ended | ||
|---|---|---|
| March 31, 2025 | March 31, 2024 | |
| Transportation | $58,489 | $66,516 |
| Industrial | 32,448 | 31,064 |
| Medical | 19,131 | 16,901 |
| Aerospace & Defense | 15,701 | 11,269 |
| Total | $125,769 | $125,750 |
NOTE 3 – Accounts Receivable, net
The components of accounts receivable, net are as follows:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Accounts receivable, gross | $82,235 | $78,379 |
| Less: Allowance for credit losses | (795) | (730) |
| Accounts receivable, net | $81,440 | $77,649 |
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2024 | 2023 | |
| Accounts receivable, gross | $81,389 | $79,500 |
| Less: Allowance for credit losses | (726) | (931) |
| Accounts receivable, net | $80,663 | $78,569 |
NOTE 4 – Inventories, net
Inventories, net consists of the following:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Finished goods | $11,886 | $12,126 |
| Work-in-process | 24,365 | 22,331 |
| Raw materials | 31,341 | 31,818 |
| Less: Inventory reserves | (13,709) | (13,963) |
| Inventories, net | $53,883 | $52,312 |
NOTE 5 – Property, Plant and Equipment, net
Property, plant and equipment, net is comprised of the following:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Land and land improvements | $399 | $399 |
| Buildings and improvements | 73,165 | 73,011 |
| Machinery and equipment | 269,068 | 265,950 |
| Less: Accumulated depreciation | (248,846) | (245,003) |
| Property, plant and equipment, net | $93,786 | $94,357 |
Depreciation expense for the three months ended March 31, 2025 and March 31, 2024 was $4,463 and $4,500, respectively.
NOTE 6 – Goodwill and Other Intangible Assets
Goodwill
Changes in the net carrying amount of goodwill were as follows:
| Total | |
|---|---|
| Goodwill as of December 31, 2024 | $201,304 |
| Foreign exchange impact | 2,051 |
| Goodwill as of March 31, 2025 | $203,355 |
Other Intangible Assets
Other intangible assets, net consist of the following components:
| As of | |||
|---|---|---|---|
| GrossCarrying Amount | AccumulatedAmortization | Net Amount | |
| Customer lists/relationships | $212,694 | $(76,109) | $136,585 |
| Technology and other intangibles | 61,562 | (36,213) | 25,349 |
| Other intangible assets, net | $274,256 | $(112,322) | $161,934 |
| As of | |||
|---|---|---|---|
| GrossCarrying Amount | AccumulatedAmortization | Net Amount | |
| Customer lists/relationships | $210,354 | $(72,500) | $137,854 |
| Technology and other intangibles | 61,244 | (35,216) | 26,028 |
| Other intangible assets, net | $271,598 | $(107,716) | $163,882 |
Amortization expense for the three months ended March 31, 2025 and March 31, 2024 was $4,031 and $2,825, respectively. The changes in the gross carrying amounts of intangible assets are due to foreign exchange impacts in the quarter.
Remaining amortization expense for other intangible assets as of March 31, 2025 is as follows:
| Amortizationexpense | |
|---|---|
| Remaining 2025 | $11,971 |
| 2026 | 15,855 |
| 2027 | 15,794 |
| 2028 | 15,759 |
| 2029 | 14,590 |
| Thereafter | 87,965 |
| Total amortization expense | $161,934 |
NOTE 7 – Costs Associated with Exit and Restructuring Activities
Restructuring charges are reported as a separate line within operating earnings in the Condensed Consolidated Statements of Earnings.
Total restructuring charges are as follows:
| Three Months Ended | ||
|---|---|---|
| March 31, 2025 | March 31, 2024 | |
| Restructuring charges | $451 | $1,693 |
During the period ended March 31, 2025, we incurred total restructuring charges of $451, comprised of $393, $21, and $37 in workforce reduction, building and equipment relocation costs, and asset impairment and other charges, respectively. The workforce reduction charges incurred are for restructuring activities used to adjust our business in response to reduced demand across certain locations and products. Restructuring charges incurred in relation to building and equipment relocation costs and other charges are for activities intended to consolidate operations across our site locations. The remaining liability associated with our other restructuring actions was $738 and $798 at March 31, 2025 and December 31, 2024, respectively.
The following table displays the restructuring liability activity included in accrued expenses and other liabilities for thethree months ended March 31, 2025:
| Restructuring liability at December 31, 2024 | $798 |
|---|---|
| Restructuring charges | 451 |
| Costs paid | (511) |
| Restructuring liability at March 31, 2025 | $738 |
NOTE 8 – Accrued Expenses and Other Liabilities
The components of accrued expenses and other liabilities are as follows:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Accrued product-related costs | $2,267 | $1,866 |
| Accrued income taxes | 5,506 | 5,418 |
| Accrued property and other taxes | 1,508 | 1,518 |
| Accrued professional fees | 1,760 | 1,625 |
| Accrued customer-related liabilities | 1,704 | 2,113 |
| Dividends payable | 1,199 | 1,201 |
| Remediation reserves | 12,035 | 12,192 |
| Derivative liabilities | 1,819 | 334 |
| Other accrued liabilities | 4,302 | 9,094 |
| Total accrued expenses and other liabilities | $32,100 | $35,361 |
NOTE 9 – Commitments and Contingencies
Certain processes in the manufacture of our current and past products may create by-products classified as hazardous waste. As a result, we have been notified by the U.S. Environmental Protection Agency (“EPA”), state environmental agencies and in some cases, groups of potentially responsible parties, that we may be potentially liable for environmental contamination at several sites currently or formerly owned or operated by us. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company. Two of those sites, Asheville, North Carolina (the “Asheville Site”) and Mountain View, California, are designated National Priorities List sites under the EPA’s Superfund program. We accrue a liability for probable remediation activities, claims, and proceedings against us with respect to environmental matters if the amount can be reasonably estimated, and provide disclosures including the nature of a loss whenever it is probable or reasonably possible that a potentially material loss may have occurred but cannot be estimated. We record contingent loss accruals on an undiscounted basis.
A roll-forward of remediation reserves included in accrued expenses and other liabilities on the Condensed Consolidated Balance Sheets is comprised of the following:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Balance at beginning of period | $12,192 | $12,044 |
| Remediation expense | 225 | 1,701 |
| Net remediation payments | (388) | (1,554) |
| Other activity(1) | 6 | 1 |
| Balance at end of the period | $12,035 | $12,192 |
(1)
Other activity includes currency translation adjustments not recorded through remediation expense.
The Company operates under and in accordance with a federal consent decree, dated March 7, 2017, with the EPA for the Asheville Site. On February 8, 2023, the Company received a letter from the EPA (the “EPA Letter”) seeking reimbursement of its past response costs and interest thereon relating to any release or threatened release of hazardous substances at the Asheville Site in the aggregate amount of $9,955 from the three potentially responsible parties associated with the Asheville Site, including the Company. The Company expects its potential exposure to be between $1,900 and $9,955. We have determined that no point within this range is more likely than another and therefore we have recorded a loss estimate of $1,900 as of March 31, 2025 and December 31, 2024 in the Consolidated Balance Sheets.
Unrelated to the environmental claims described above, certain other legal claims are pending against us with respect to matters arising out of the ordinary conduct of our business.
We provide product warranties when we sell our products and accrue for estimated liabilities at the time of sale. Warranty estimates are forecasts based on the best available information and historical claims experience. We accrue for specific warranty claims if we believe that the facts of a specific claim make it probable that a liability in excess of our historical experience has been incurred and provide disclosures for specific claims whenever it is reasonably possible that a material loss may be incurred which cannot be estimated.
We cannot provide assurance that the ultimate disposition of environmental, legal, and product warranty claims will not materially exceed the amount of our accrued losses and adversely impact our consolidated financial position, results of operations, or cash flows. Our accrued liabilities and disclosures will be adjusted accordingly if additional information becomes available in the future.
NOTE 10 - Debt
Long-term debt is comprised of the following:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Total credit facility | $400,000 | $400,000 |
| Balance outstanding | 86,700 | 92,300 |
| Standby letters of credit | 1,640 | 1,640 |
| Amount available, subject to covenant restrictions | $311,660 | $306,060 |
| Weighted-average interest rate | 5.70% | 6.41% |
On December 15, 2021, we entered into a second amended and restated five-year credit agreement with a group of banks (the “Revolving Credit Facility”) to (i) increase the total credit facility to $400,000, which may be increased by $200,000 at the request of the Company, subject to the administrative agent's approval, (ii) extend the maturity of the Revolving Credit Facility from February 12, 2024 to December 15, 2026, (iii) replace LIBOR with SOFR as the primary reference rate used to calculate interest on the loans under the Revolving Credit Facility, (iv) increase available sub limits for letters of credit and swingline loans as well as providing for additional alternative currency borrowing capabilities, and (v) modify the financial and non-financial covenants to provide the Company additional flexibility. This unsecured credit facility replaced the prior $300,000 unsecured credit facility, which would have expired February 12, 2024.
Borrowings in U.S. dollars under the Revolving Credit Facility bear interest, at a per annum rate equal to the applicable Term SOFR rate (but not less than 0.0%), plus the Term SOFR adjustment, and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio. Similarly, borrowings of alternative currencies under the Revolving Credit Facility bear interest equal to a defined risk-free reference rate, plus the applicable risk-free rate adjustment and plus an applicable margin, which ranges from 1.00% to 1.75%, based on our net leverage ratio. We use interest rate swaps to convert a portion of our revolving credit facility's outstanding balance from a variable rate of interest to a fixed rate. The contractual rate of these arrangements ranges from 1.49% to 2.45%. Refer to Note 11, “Derivative Financial Instruments,” for further discussion on the impact of interest rate swaps.
The Revolving Credit Facility includes a swingline sublimit of $20,000 and a letter of credit sublimit of $20,000. We also pay a quarterly commitment fee on the unused portion of the Revolving Credit Facility. The commitment fee ranges from 0.175% to 0.25% based on our net leverage ratio.
The Revolving Credit Facility requires, in addition to customary representations and warranties, that we comply with a maximum net leverage ratio and a minimum interest coverage ratio. Failure to comply with these covenants could reduce the borrowing availability under the Revolving Credit Facility. We were in compliance with all debt covenants at March 31, 2025. The Revolving Credit Facility requires that we deliver quarterly financial statements, annual financial statements, auditor certifications, and compliance certificates within a specified number of days after the end of a quarter and year. Additionally, the Revolving Credit Facility contains restrictions limiting our ability to: dispose of assets; incur certain additional debt; repay other debt or amend subordinated debt instruments; create liens on assets; make investments, loans or advances; make acquisitions or engage in mergers or consolidations; engage in certain transactions with our subsidiaries and affiliates; and make stock repurchases and dividend payments.
We have debt issuance costs related to our long-term debt that are being amortized using the straight-line method over the life of the debt, which approximates the effective interest method. Amortization expense for the three months ended March 31, 2025 and March 31, 2024 were $48 and $48, respectively. These costs are included in interest expense in our Consolidated Statements of Earnings.
Note 11 - Derivative Financial Instruments
Our earnings and cash flows are subject to fluctuations due to changes in foreign currency exchange rates and interest rates. We selectively use derivative financial instruments including foreign currency forward contracts as well as interest rate and cross-currency swaps to manage our exposure to these risks.
The use of derivative financial instruments exposes the Company to credit risk, which relates to the risk of nonperformance by a counterparty to the derivative contracts. We manage our credit risk by entering into derivative contracts with only highly rated financial institutions and by using netting agreements.
The effective portion of derivative gains and losses are recorded in accumulated other comprehensive income (loss) until the hedged transaction affects earnings upon settlement, at which time they are reclassified to cost of goods sold or net sales. If it is probable that an anticipated hedged transaction will not occur by the end of the originally specified time period, we reclassify the gains or losses related to that hedge from accumulated other comprehensive income (loss) to other income (expense), net.
We assess hedge effectiveness qualitatively by verifying that the critical terms of the hedging instrument and the forecasted transaction continue to match, and that there have been no adverse developments that have increased the risk that the counterparty will default. No recognition of ineffectiveness was recorded in our Condensed Consolidated Statements of Earnings for thethree months ended March 31, 2025.
Foreign Currency Hedges
We use forward contracts to mitigate currency risk related to a portion of our forecasted foreign currency revenues and costs. The currency forward contracts are designed as cash flow hedges and are recorded in the Condensed Consolidated Balance Sheets at fair value.
We continue to monitor the Company’s overall currency exposure and may elect to add cash flow hedges in the future. At March 31, 2025, we had a net unrealized loss of $1,659 in accumulated other comprehensive income (loss), $1,723 of which is expected to be reclassified to earnings within the next 12 months. The notional amount of foreign currency forward contracts outstanding was $65,527 at March 31, 2025.
Interest Rate Swaps
We use interest rate swaps to convert a portion of our Revolving Credit Facility’s outstanding balance from a variable rate of interest to a fixed rate. As of March 31, 2025, we have agreements to fix interest rates on $50,000 of long-term debt until December 2026. The difference to be paid or received under the terms of the swap agreements will be recognized as an adjustment to interest expense when settled.
These swaps are treated as cash flow hedges and, consequently, the changes in fair value are recorded in other comprehensive (loss) income. The estimated net amount of the existing gains that are reported in accumulated other comprehensive income (loss) that are expected to be reclassified into earnings within the next twelve months is approximately $710.
Cross-Currency Swap
The Company has operations and investments in various international locations and is subject to risks associated with changing foreign exchange rates. In order to hedge the Krone-based purchase price for the acquisition of Ferroperm Piezoceramics, A.S. (“Ferroperm”), the Company entered into a cross currency interest rate swap agreement on June 27, 2022 that synthetically swapped $25,000 of variable rate debt to Krone-denominated variable rate debt. Upon completion of the Ferroperm acquisition on June 30, 2022, the transaction was designated as a net investment hedge for accounting purposes and will mature on June 30, 2027.
Accordingly, any gains or losses on this derivative instrument are included in the foreign currency translation component of other comprehensive (loss) income until the net investment is sold, diluted or liquidated. As of March 31, 2025, we had a net unrealized loss of $606 in accumulated other comprehensive income (loss). Interest payments received for the cross-currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense in the Condensed Consolidated Statements of Earnings. The assumptions used in measuring fair value of the cross-currency swap are considered level 2 inputs, which are based upon the Krone to U.S. Dollar exchange rate market.
The location and fair values of derivative instruments designated as hedging instruments in the Condensed Consolidated Balance Sheets as of March 31, 2025, are shown in the following table:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Interest rate swaps reported in Other current assets | $710 | $792 |
| Interest rate swaps reported in Other assets | 366 | 711 |
| Cross-currency swap reported in Other current assets | - | 324 |
| Cross-currency swap reported in Accrued expenses and other liabilities | (226) | - |
| Foreign currency hedges reported in Accrued expenses and other liabilities | (1,593) | (2,992) |
The Company has elected to net its foreign currency derivative assets and liabilities in the balance sheet in accordance with ASC 210-20 (Balance Sheet, Offsetting). On a gross basis, there were foreign currency derivative assets of $221 and $1,814 foreign currency derivative liabilities at March 31, 2025.
The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:
| Three Months Ended | ||
|---|---|---|
| March 31, | March 31, | |
| 2025 | 2024 | |
| Foreign Exchange Contracts: | ||
| Amounts reclassified from AOCI to earnings: | ||
| Net sales | $(40) | $26 |
| Cost of goods sold | (631) | 758 |
| Total net (loss) gain reclassified from AOCI to earnings | (671) | 784 |
| Total derivative (loss) gain on foreign exchange contracts recognized in earnings | $(671) | $784 |
| Interest Rate Swaps: | ||
| Income recorded in Interest expense | $234 | $405 |
| Cross-Currency Swap: | ||
| Income recorded in Interest expense | $72 | $94 |
| Total net (loss) gain on derivatives | $(365) | $1,283 |
NOTE 12 – Accumulated Other Comprehensive Income (Loss)
Shareholders’ equity includes certain items classified as accumulated other comprehensive income (loss) (“AOCI”) in the Condensed Consolidated Balance Sheets, including:
Unrealized gains (losses) on hedges relate to interest rate swaps to convert a portion of our Revolving Credit Facility's outstanding balance from a variable rate of interest into a fixed rate, foreign currency forward contracts used to hedge our exposure to changes in exchange rates affecting certain revenues and costs denominated in foreign currencies, as well as a cross-currency swap that synthetically converts our U.S. Dollar variable rate debt to Krone-denominated variable rate debt. These hedges are designated as cash flow hedges, and we have deferred income statement recognition of gains and losses until the hedged transactions occur, at which time amounts are reclassified into earnings. Further information related to our derivative financial instruments is included in Note 11, “Derivative Financial Instruments” and Note 15, “Fair Value Measurements.”
Unrealized gains (losses) on pension obligations are deferred from income statement recognition until the gains or losses are realized. Amounts reclassified to income from AOCI are included in net periodic pension income (expense).
Cumulative translation adjustments relate to our non-U.S. subsidiary companies that have designated a functional currency other than the U.S. Dollar. We are required to translate the subsidiary functional currency financial statements to dollars using a combination of historical, period-end, and average foreign exchange rates. This combination of rates creates the foreign currency translation adjustment component of other comprehensive income (loss).
Changes in exchange rates between the functional currency and the currency in which a transaction is denominated are foreign exchange transaction gains or losses. Transaction losses for the three months ended March 31, 2025 and March 31, 2024 were $513 and $1,507, respectively. The impact of these changes have been included in other income (expense) in the Condensed Consolidated Statements of Earnings.
The components of accumulated other comprehensive income (loss) for thethree months ended March 31, 2025, are as follows:
| (Gain) Loss | ||||
|---|---|---|---|---|
| As of | Gain (Loss) | Reclassified | As of | |
| December 31, | Recognized | from AOCI | March 31, | |
| 2024 | in OCI | to Earnings | 2025 | |
| Changes in fair market value of derivatives: | ||||
| Gross | $(1,730) | $708 | $437 | $(585) |
| Income tax benefit (expense) | 397 | (166) | (103) | 128 |
| Net | (1,333) | 542 | 334 | (457) |
| Changes in unrealized pension cost: | ||||
| Gross | (409) | — | 14 | (395) |
| Income tax benefit (expense) | 300 | — | — | 300 |
| Net | (109) | — | 14 | (95) |
| Cumulative translation adjustment: | ||||
| Gross | (2,824) | 4,648 | — | 1,824 |
| Income tax benefit (expense) | — | — | — | — |
| Net | (2,824) | 4,648 | — | 1,824 |
| Total accumulated other comprehensive (loss) income | $(4,266) | $5,190 | $348 | $1,272 |
The components of accumulated other comprehensive income (loss) for the three months ended March 31, 2024, are as follows:
| (Gain) Loss | ||||
|---|---|---|---|---|
| As of | Gain (Loss) | Reclassified | As of | |
| December 31, | Recognized | from AOCI | March 31, | |
| 2023 | in OCI | to Earnings | 2024 | |
| Changes in fair market value of derivatives: | ||||
| Gross | $3,252 | $2,138 | $(1,189) | $4,201 |
| Income tax (expense) benefit | (749) | (492) | 274 | (967) |
| Net | 2,503 | 1,646 | (915) | 3,234 |
| Changes in unrealized pension cost: | ||||
| Gross | (1,126) | — | 69 | (1,057) |
| Income tax benefit (expense) | 442 | — | (5) | 437 |
| Net | (684) | — | 64 | (620) |
| Cumulative translation adjustment: | ||||
| Gross | 2,445 | (2,121) | — | 324 |
| Income tax benefit (expense) | — | — | — | — |
| Net | 2,445 | (2,121) | — | 324 |
| Total accumulated other comprehensive income (loss) | $4,264 | $(475) | $(851) | $2,938 |
NOTE 13 – Shareholders’ Equity
Share count and par value data related to shareholders’ equity are as follows:
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| Preferred Stock | ||
| Par value per share | No par value | No par value |
| Shares authorized | 25,000,000 | 25,000,000 |
| Shares outstanding | — | — |
| Common Stock | ||
| Par value per share | No par value | No par value |
| Shares authorized | 75,000,000 | 75,000,000 |
| Shares issued | 57,620,771 | 57,543,964 |
| Shares outstanding | 29,959,311 | 30,026,045 |
| Treasury stock | ||
| Shares held | 27,661,460 | 27,517,919 |
On February 2, 2024, our Board of Directors approved a share repurchase program that authorizes the Company to repurchase up to $100,000 of its common stock. The repurchase program has no set expiration date and supersedes and replaces the repurchase program approved by the Board of Directors in February 2023. The purchases may be made from time to time in the open market (including, without limitation, through the use of Rule 10b5-1 plans), depending on a number of factors, including our evaluation of general market and economic conditions, our financial condition and the trading price of our common stock. The repurchase program may be extended, modified, suspended or discontinued at any time.
During the three months ended March 31, 2025,143,541 shares of common stock were repurchased for $6,650 under the 2024 repurchase program. During the three months ended March 31, 2024,271,939 shares of common stock were repurchased for $12,078. As of March 31, 2025, approximately $54,772 remains available for future purchases.
We are subject to a 1% excise tax on stock repurchases under the United States Inflation Reduction Act of 2022 which we include in the cost of stock repurchases as a reduction of shareholders’ equity. As of March 31, 2025 and December 31, 2024, we had $6 and $741, respectively, recorded in Accrued expenses and other liabilities in the Consolidated Balance Sheet.
A roll-forward of shares of common stock outstanding is as follows:
| Three Months Ended | ||
|---|---|---|
| March 31, | March 31, | |
| 2025 | 2024 | |
| Balance at the beginning of the year | 30,026,045 | 30,824,248 |
| Repurchases | (143,541) | (271,939) |
| Restricted share issuances | 76,807 | 96,790 |
| Balance at the end of the period | 29,959,311 | 30,649,099 |
Certain potentially dilutive restricted stock units are excluded from diluted earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the three months ended March 31, 2025 and March 31, 2024 were 165 and 30,030, respectively.
NOTE 14- Stock-Based Compensation
At March 31, 2025, we hadfive active stock-based compensation plans: the Non-Employee Directors’ Stock Retirement Plan (“Directors’ Plan”), the 2004 Omnibus Long-Term Incentive Plan (“2004 Plan”), the 2009 Omnibus Equity and Performance Incentive Plan (“2009 Plan”), the 2014 Performance and Incentive Compensation Plan (“2014 Plan”), and the 2018 Equity and Incentive Compensation Plan (“2018 Plan”). Future grants can only be made under the 2018 Plan.
The 2018 Plan allows for grants of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance shares, performance units, and other stock awards subject to the terms of the 2018 Plan.
The following table summarizes the compensation expense included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings related to stock-based compensation plans:
| Three Months Ended | ||
|---|---|---|
| March 31, | March 31, | |
| 2025 | 2024 | |
| Service-based RSUs | $947 | $894 |
| Performance and Market-based RSUs | 485 | 154 |
| Cash-settled RSUs | 215 | 173 |
| Total | $1,647 | $1,221 |
| Income tax benefit | 387 | 279 |
| Net expense | $1,260 | $942 |
The following table summarizes the unrecognized compensation expense related to unvested RSUs by type and the weighted-average period in which the expense is to be recognized:
| Unrecognized | ||
|---|---|---|
| Compensation | Weighted- | |
| Expense at | Average | |
| March 31, 2025 | Period (years) | |
| Service-based RSUs | $4,291 | 1.47 |
| Performance and Market-based RSUs | 4,901 | 2.24 |
| Total | $9,192 | 1.88 |
We recognize expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.
The following table summarizes the status of these plans as of March 31, 2025:
| 2018 Plan | 2014 Plan | 2009 Plan | 2004 Plan | Directors'Plan | |
|---|---|---|---|---|---|
| Awards originally available | 2,500,000 | 1,500,000 | 3,400,000 | 6,500,000 | N/A |
| Maximum potential awards outstanding | 650,602 | 39,400 | 34,100 | 14,545 | 4,722 |
| RSUs and cash-settled awards vested and released | 769,871 | — | — | — | — |
| Awards available for grant | 1,079,527 | — | — | — | — |
Service-Based Restricted Stock Units
The following table summarizes the service-based RSU activity for the three months ended March 31, 2025:
| Units | WeightedAverage Grant Date Fair Value | |
|---|---|---|
| Outstanding at December 31, 2024 | 322,847 | $34.06 |
| Granted | 43,578 | 48.15 |
| Vested and released | (54,811) | 40.33 |
| Outstanding at March 31, 2025 | 311,614 | $34.92 |
| Releasable at March 31, 2025 | 159,156 | $23.85 |
Performance-Based Restricted Stock Units
The following table summarizes the performance-based RSU activity for the three months ended March 31, 2025:
| Units | WeightedAverage Grant Date Fair Value | |
|---|---|---|
| Outstanding at December 31, 2024 | 222,344 | $40.15 |
| Granted | 59,215 | 47.73 |
| Attained by performance | 40,549 | 37.93 |
| Released | (79,162) | 37.93 |
| Forfeited | (48,682) | 37.93 |
| Outstanding at March 31, 2025 | 194,264 | $44.83 |
| Releasable at March 31, 2025 | — | $— |
Cash-Settled Restricted Stock Units
Cash-Settled RSUs entitle the holder to receive the cash equivalent of one share of common stock for each unit when the unit vests. These RSUs are issued to key employees residing in foreign locations as direct compensation. Generally, these RSUs vest over a three-year period. Cash-Settled RSUs are classified as liabilities and are remeasured at each reporting date until settled. At March 31, 2025 and December 31, 2024, we had 15,028 and 44,127 Cash-Settled RSUs outstanding, respectively. At March 31, 2025 and December 31, 2024, liabilities of $274 and $608, respectively, were included in accrued expenses and other liabilities on our Condensed Consolidated Balance Sheets.
NOTE 15 — Fair Value Measurements
The table below summarizes our financial assets and liabilities that were measured at fair value on a recurring basis at March 31, 2025:
| Asset (Liability) CarryingValue atMarch 31,2025 | Quoted Pricesin ActiveMarkets forIdentical(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) | |
|---|---|---|---|---|
| Interest rate swaps | $1,076 | $— | $1,076 | $— |
| Foreign currency hedges | $(1,593) | $— | $(1,593) | $— |
| Cross-currency swap | $(226) | $— | $(226) | $— |
| Qualified replacement plan assets | $10,695 | $10,695 | $— | $— |
| Contingent consideration | $(6,866) | $— | $— | $(6,866) |
The table below summarizes the financial assets and liabilities that were measured at fair value on a recurring basis at December 31, 2024:
| Asset (Liability) CarryingValue atDecember 31,2024 | Quoted Pricesin ActiveMarkets forIdentical(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) | |
|---|---|---|---|---|
| Interest rate swaps | $1,503 | $— | $1,503 | $— |
| Foreign currency hedges | $(2,992) | $— | $(2,992) | $— |
| Cross-currency swap | $324 | $— | $324 | $— |
| Qualified replacement plan assets | $11,380 | $11,380 | $— | $— |
| Contingent consideration | $(7,028) | $— | $— | $(7,028) |
We use interest rate swaps to convert a portion of our Revolving Credit Facility’s outstanding balance from a variable rate of interest into a fixed rate and foreign currency forward contracts to hedge the effect of foreign currency changes on certain revenues and costs denominated in foreign currencies. The Company entered into a cross-currency swap agreement in order to manage its exposure to changes in interest rates related to foreign debt. These derivative financial instruments are measured at fair value on a recurring basis. The fair value of our interest rate swaps and foreign currency hedges were measured using standard valuation models using market-based observable inputs over the contractual terms, including forward yield curves, among others. There is a readily determinable market for these derivative instruments, but that market is not active and therefore they are classified within Level 2 of the fair value hierarchy.
The fair value of the contingent consideration requires significant judgment. The Company's fair value estimates used in the contingent consideration valuation are considered Level 3 fair value measurements. The fair value estimates were based on assumptions management believes to be reasonable, but that are inherently uncertain, including estimates of future revenues and timing of events and activities that are expected to take place.
A roll-forward of the contingent consideration is as follows:
| ContingentConsideration | |
|---|---|
| Balance at December 31, 2024 | $7,028 |
| Change in fair value | (162) |
| Balance at March 31, 2025 | $6,866 |
As of March 31, 2025, all contingent consideration was recorded in other long-term obligations on our Condensed Consolidated Balance Sheets.
Our long-term debt consists of the Revolving Credit Facility, which is recorded at its carrying value. There is a readily determinable market for our long-term debt and it is classified within Level 2 of the fair value hierarchy as the market is not deemed to be active. The fair value of long-term debt approximates its carrying value and was determined by valuing a similar hypothetical coupon bond and attributing that value to our long-term debt under the Revolving Credit Facility.
The qualified replacement plan assets consist of investment funds maintained for future contributions to the Company’s U.S. 401(k) program. The investments are Level 1 marketable securities and are recorded in Other Assets on our Condensed Consolidated Balance Sheets.
NOTE 16 — Income Taxes
The effective tax rates for thethree months ended March 31, 2025 and March 31, 2024 are as follows:
| Three Months Ended | ||
|---|---|---|
| March 31, | March 31, | |
| 2025 | 2024 | |
| Effective tax rate | 17.1% | 18.6% |
The decrease in the effective income tax rate is primarily attributed to a change in mix of earnings taxed at lower rates and the establishment of valuation allowances on certain tax credits in the first quarter of 2024. The first quarter 2024 and 2025 effective income tax rates were lower than the U.S. statutory federal income tax rate primarily due to foreign earnings that are taxed at lower rates and tax benefits recorded upon vesting of RSUs.
NOTE 17 — Segment Information
The Company designs, manufactures, and sells a broad line of sensors, connectivity components, and actuators across multiple end markets in North America, Asia, and Europe. Our Chief Operating Decision Maker (“CODM”), who is our Chair, President and Chief Executive Officer, analyzes the results of our business throughone reportable segment. Our CODM evaluates the operating results and performance through Net earnings, which are reported on the Consolidated Statements of Earnings. These financial metrics are used to view operating trends, perform analytical comparisons and benchmark performance between periods and to monitor budget-to-actual variances on a monthly basis. To manage operations and make decisions regarding resources, our CODM is regularly provided and reviews expense information at a consolidated level for our Cost of goods sold, Selling, general, and administrative expenses and Research and Development expenses, which are reported on the Consolidated Statements of Earnings. As part of our strategic planning and annual operating plan, a focus is on sales growth, diversification, and profitability. The measure of segment assets is reported on the Consolidated Balance Sheet as Total Assets, but the CODM does not use discrete balance sheet information in assessing performance and allocating resources.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.